ClinicalTrials.gg
RecruitingNCT06885190Updated Oct 27, 2026

Multisensory Processing of Alcohol Cues in Young Adult Binge Drinkers

An interventional study of Presentation of alcohol-related and neutral stimuli in Drinking, Binge, sponsored by Rochester Institute of Technology. Recruiting at 1 site in United States. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Rochester Institute of Technology · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Jul 2026; still recruiting 3 months later.
Updated Oct 27, 2026Eligibility revisedDesign changed+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years to 25 Years
Sex
All
01

Study summary

Binge drinking is common among young adults and is related to many negative health outcomes including blackouts, risky sex, drunk driving, alcohol use disorder, and liver disease. Understanding whether there are differences in how binge drinkers respond to alcohol-related cues and whether this is related to craving is important for improving interventions and treatments. The proposed study will compare behavioral and neural processing of alcohol and non-alcohol cues in a single sensory modality (vision) with that of cues presented in multiple sensory modalities (vision, touch, and smell) with varying degrees of realistic appearance (images, virtual reality, real objects). Participants will answer questionnaires related to their physical and mental health and recent alcohol and drug use. Those eligible for the study will complete two in-person lab sessions. During both sessions they will be asked to view a series of cues which will include images on a computer screen, objects presented in virtual reality, or real objects. Sometimes these will be presented just visually and other times they will be combined with the presentation of specific smells or an object to touch. Some of these cues will be alcohol-related and others will be neutral (non-alcohol-related). Brainwave activity, as measured by the electroencephalogram (EEG), and reports of alcohol craving will be collected during these sessions. It is expected that brainwave activity will be greatest in response to multisensory cues compared to that in response unisensory (visual only) cues. It is also expected that young adults with a recent history of binge drinking will show the greatest brainwave activity in response to multisensory alcohol cues compared to social drinkers. Binge drinkers will also report more alcohol craving in response to multisensory alcohol cues compared to social drinkers. It is anticipated that brainwave responses will increase as the level of realism of the cues increases. Binge drinkers will also show stronger brainwave and craving responses to multisensory alcohol cues presented as real objects. Finally, binge drinkers will show lessened brain and craving responses when multisensory cues do not match compared to social drinkers. For example, if a photo shows an alcoholic drink but the smell presented is not alcohol related, binge drinkers will show less attentive brain activity toward those mismatched cues. Given that most alcohol cues in daily life are experienced across multiple senses simultaneously, results of this research will provide a better understanding of the relation between alcohol cue processing and craving, and will inform development of more effective programs for decreasing young adult risky drinking behavior.

02

Conditions studied

  • Drinking, Binge

Browse trials for

Keywords

  • alcohol
  • young adult
  • multisensory
  • cues
  • event-related potentials
  • virtual reality
03

In context

Binge Drinking

71 studies on the registry are indexed under Binge Drinking; 20 are open to participants now.

This study's planned enrollment of 100 is below the median of 120 across 64 interventional studies indexed under Binge Drinking.

Browse Binge Drinking studies →

Lead sponsor

Rochester Institute of Technology is the lead sponsor of 6 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ages 18 to 25 years old
  • meet criteria for either the binge drinker or social drinker groups previously described

Exclusion criteria

Exclusion Criteria:

  • history of head injury involving loss of consciousness of 10+ minutes
  • colorblindness
  • hearing, tactile, olfactory or uncorrected vision deficits
  • history of seizures
  • neurological disorder diagnosis
  • mental health history of psychosis or mania
  • history of alcohol or substance use disorder diagnosis
  • illicit drug use in the past 30 days
  • changes to psychotropic medication type or dose in past 3 months
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Young Adult Binge Drinkers

    Participants ages 18 to 25 with a history of binge drinking (at least 2 episodes of 5+ standard drinks per episode for males/4+ standard drinks per episode for females) in the past month and at least 4+/3+ (males/females) score on the Alcohol Use Disorder Identification Test.

    Other: Presentation of alcohol-related and neutral stimuli

  • Active comparator
    Young Adult Social Drinkers

    Participants ages 18 to 25 who report drinking alcohol at least once in the past month but no current history of a binge pattern (i.e., 2 or fewer drinks per episode) AND score less than 4/3 (males/females) on the Alcohol Use Disorder Identification Test.

    Other: Presentation of alcohol-related and neutral stimuli

Interventions

  • OtherPresentation of alcohol-related and neutral stimuli

    Participants will complete two tasks in which they will be presented with unisensory visual and multisensory stimuli combining visual, olfactory, and/or tactile sensory modalities. Stimulus content will be either alcohol-related or neutral (non-alcohol-related). Additionally in the Passive Viewing Task, stimuli will vary on the degree of visual realism. Specifically, participants will be presented with two-dimensional images, three-dimensional virtual reality simulations, and real physical objects. In the second task, a Cross-modal Stroop-like task, participants will be asked to press a button to indicate whether the presented stimuli match in terms of the content presented in each sensory modality. Electroencephalographic (EEG) brain activity, eye movements, responses, and self-reported craving will be collected while participants complete the tasks.

06

What researchers measure

Primary outcomes

  1. Event-related Potential Amplitudes in Response to Alcohol and Neutral Cues

    Amplitude (magnitude) of electrocortical activity assessed in response to alcohol-related and neutral cues presented either visually or in visual-olfactory or visual-tactile combinations.

    Time frame: Baseline and follow-up (within 1 week)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Hill-Bowen LD, Riedel MC, Poudel R, Salo T, Flannery JS, Camilleri JA, Eickhoff SB, Laird AR, Sutherland MT. The cue-reactivity paradigm: An ensemble of networks driving attention and cognition when viewing drug and natural reward-related stimuli. Neurosci Biobehav Rev. 2021 Nov;130:201-213. doi: 10.1016/j.neubiorev.2021.08.010. Epub 2021 Aug 13. PubMed 34400176 ↗
  • Connor JP, Kavanagh DJ, Andrade J, May J, Feeney GF, Gullo MJ, White AM, Fry ML, Drennan J, Previte J, Tjondronegoro D. Alcohol consumption in young adults: the role of multisensory imagery. Addict Behav. 2014 Mar;39(3):721-4. doi: 10.1016/j.addbeh.2013.11.023. Epub 2013 Dec 4. PubMed 24360399 ↗
  • Kiyak C, Simonetti ME, Norton S, Deluca P. The efficacy of cue exposure therapy on alcohol use disorders: A quantitative meta-analysis and systematic review. Addict Behav. 2023 Apr;139:107578. doi: 10.1016/j.addbeh.2022.107578. Epub 2022 Dec 12. PubMed 36563480 ↗
  • Mellentin AI, Skot L, Nielsen B, Schippers GM, Nielsen AS, Stenager E, Juhl C. Cue exposure therapy for the treatment of alcohol use disorders: A meta-analytic review. Clin Psychol Rev. 2017 Nov;57:195-207. doi: 10.1016/j.cpr.2017.07.006. Epub 2017 Jul 27. PubMed 28781153 ↗
  • Hone-Blanchet A, Wensing T, Fecteau S. The use of virtual reality in craving assessment and cue-exposure therapy in substance use disorders. Front Hum Neurosci. 2014 Oct 17;8:844. doi: 10.3389/fnhum.2014.00844. eCollection 2014. PubMed 25368571 ↗

Individual participant data

Plan to share: No

09

Updates

2 registry updates since Sep 25, 2026
Eligibility
Revised
Oct 27, 2026
Interventions
Arms or interventions changed
Oct 1, 2026
Design
Study type Observational→Interventional
Oct 27, 2026
Show all 2 updates
  1. Oct 27, 2026
    Eligibility Revised
    Design Study type Observational→Interventional
    + 2 other changes: verification date and arm descriptions
  2. Oct 1, 2026
    Interventions Arms or interventions changed
    + 2 other changes: index terms and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06885190
Lead sponsor
Rochester Institute of Technology
Responsible party
Rebecca Houston (Associate Professor, Rochester Institute of Technology) — Principal investigator
First posted
Mar 20, 2025
Start date
Jul 31, 2026
Primary completion
Aug 15, 2027 (estimated)
Completion
Aug 15, 2027 (estimated)
Last update
Oct 27, 2026

Study contacts

Rebecca J Houston, PhD
Contact
rjhgss@rit.edu
585-475-5205
Elena Fedorovskaya, PhD
Contact
eafppr@rit.edu
585-475-6952
Rebecca J Houston, PhD
principal investigator · Rochester Institute of Technology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion